New study determines cystic fibrosis therapy is safe and effective for young children ...Middle East

- News
New study determines cystic fibrosis therapy is safe and effective for young children
Children ages two to five who have the most common form of cystic fibrosis have not had any modulator treatments available to them until recently. A new study authored by researchers at Children's Hospital Colorado and published May 6, 2021, in Lancet Respiratory Medicine shows that the CFTR modulator - lumacaftor/ivacaftor - can be safe and well-tolerated for this age range for up to 120 weeks, allowing younger children to begin proactive treatment of CF.

Hence then, the article about new study determines cystic fibrosis therapy is safe and effective for young children was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New study determines cystic fibrosis therapy is safe and effective for young children )

Apple Storegoogle play

Last updated :

Also on site :



Latest News